Prospective Athlete's Heart Study (Pro@Heart)

Universitaire Ziekenhuizen KU Leuven

Status: Enrolling

Conditions: Athlete Heart

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05164328

57241

Details and patient eligibility

About

The Pro@Heart (Prospective Athlete's Heart) study is an international multicentre long-term prospective trial. The primary objective of the Pro@Heart study is to investigate the impact of training load (i.e. accurately evaluated in term of type, frequency, duration and intensity) and genotype on the variability of structural, functional and electrical exercise induced cardiac remodeling (EICR) in young competitive endurance athletes. The second objective is to determine how EICR, training load and genotype are associated with physical performance, health benefits and cardiac pathology (e.g. exercise-related cardiomyopathies and arrhythmias) during follow-up over several decades.

Enrollment: 450 estimated patients

Sex: All

Ages: 14 to 23 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Males and females aged 14-23 years old

2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include:

   1. Triathlon
   2. Cycling
   3. Distance running (≥ 1500 meters)
   4. Rowing
   5. Swimming

3. Non athletes engaged in < 3 hours per week of physical activity

Exclusion criteria

1. Medical history of cardiovascular disease
2. Current smoker of past history of smoking
3. Diabetes mellitus

Trial design

450 participants in 2 patient groups

Athletes

Description:

1. Males and females aged 14-23 years old 2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include: 1. Triathlon 2. Cycling 3. Distance running (≥ 1500 meters) 4. Rowing 5. Swimming

Treatment:

Other: No intervention

Non-athletes

Description:

1. Males and females aged 14-23 years old 2. Non athletes engaged in \< 3 hours per week of physical activity

Treatment:

Other: No intervention